Trial intelligence / Profile preview

STAPRA atorvastatin prevention trial in seropositive arthralgia

NL-OMON44914Not yet recruiting

Sponsor
Amsterdam Rheumatology & immunology Center | Reade
Start
Aug 2015
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in rheumatoid arthritis (RA) comparing Atorvastatin with Placebo (2 arms). Primary endpoint: Development of clinical arthritis. Planned start Aug 2015; status: not yet recruiting.

02

Drugs

atorvastatin
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NL-OMON44914.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON44914.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call